Bioglutide NA-931 Quadruple Receptor Agonist Mechanism piav qhia

Cov kev hloov pauv loj tau tshwm sim nrog cov tshuaj noj mob metabolic. Ntau tshaj 650 lab tus tib neeg thoob ntiaj teb muaj teeb meem metabolic lossis rog dhau, yog li cov kws kho mob tau tshawb nrhiav dhau ib qho - hom phiaj kho. Txiav- ntug qhov ncauj me me moleculeTom ntej: Bioglutide NA-931hloov metabolic kev cai paradigms. Cov tshuaj tshiab no cuam tshuam rau plaub txoj hauv kev metabolic ib txhij tsis yog ib qho, zoo li lwm yam tshuaj. Ib qho kev ua haujlwm sib koom ua ke kho ntau yam kev ua tsis tiav hauv metabolic.

 

Tom ntej: Bioglutide NA-931

1. General Specification (hauv Tshuag)
(1) API (Ntshiab hmoov)
PE / Al foil hnab / ntawv lub thawv rau cov hmoov ntshiab
(2) Spot-On
(3) Kev daws teeb meem
(4) Poob
2.Customization:
Peb yuav sib tham tus kheej, OEM / ODM, Tsis muaj hom, rau kev tshawb nrhiav kev ruaj ntseg nkaus xwb.
Khoom siv: BM-1-154
TIAB SA-931
Kev tshuaj xyuas: HPLC, LC-MS, HNMR
Kev them nyiaj yug Technology: R & D Dept.-3

Peb muab tetracaine hmoov, thov xa mus rau lub vev xaib hauv qab no kom paub meej cov lus qhia thiab cov ntaub ntawv khoom.

Khoom siv:https://www.bloomtechz.com/synthetic-chemical/peptide/bioglutide-na-931.html

Bioglutide NA-931's plaub-receptor mechanism yuav tsum raug tshuaj xyuas kom nkag siab txog nws cov txheej txheem. Qhov kev kho ntau lub hom phiaj no ua rau cov tshuaj hormones metabolic zoo dua li lwm yam. Qhov no txhawb nqa ntau lab tus rog rog thiab hom 2 mob ntshav qab zib. Qhov sib xyaw ua ke ntawm kev ua haujlwm ib txhij ntawm kev tswj hwm cov piam thaj, kev tshaib kev nqhis, thiab cov leeg nqaij noj qab haus huv, kev nce qib loj hauv kev tshawb fawb tshuaj.

Bioglutide NA-931 yog tsim los vim cov kab mob metabolic yog cov teeb meem nyuaj, ntau lub cev uas xav tau kev kho mob dav dav. Cov tshuaj niaj hnub uas kho ib cheeb tsam ntawm metabolic tsis ua haujlwm tuaj yeem tsim lwm yam teeb meem thiab ua tsis tiav. Cov tshuaj tshiab no ua rau plaub lub receptors ua ke ib txhij los muab cov lus teb sib luag zoo li lub cev hauv kev noj qab haus huv.

Plaub Receptor Targets ntawm Bioglutide NA-931 yog dab tsi hauv Kev Cai Metabolic?

GLP-1 Receptor: Central Appetite Control thiab Peripheral Metabolic Enhancement

Raws li ib qho ntawm nws lub hom phiaj tseem ceeb, Bioglutide NA-931 mus tom qab glucagon-zoo li peptide-1 receptor (GLP-1R). Lub hypothalamic arcuate nucleus ntawm lub hlwb muaj cov txheej txheem muaj zog uas tswj kev tshaib kev nqhis thaum cov receptor no tshwm sim. Cov tshuaj activates pro-opiomelanocortin (POMC) neurones, uas tom qab ntawd tso tawm alpha-melanocyte-stimulating hormone. Qhov no hloov ntawm melanocortin-4 receptors, uas xa cov cim qhia tias koj puv. Nyob rau tib lub sijhawm, nws nres neuropeptide Y thiab agouti-txog cov protein neurones los ntawm kev ua haujlwm, uas yog qhov ua rau peb tshaib plab.

Ntxiv nrog rau qhov muaj feem cuam tshuam rau lub hlwb, ua kom GLP-1R muaj txiaj ntsig zoo hauv metabolic hauv ib puag ncig. Hauv txoj kev ua cov piam thaj, cov receptor ua rau pancreatic beta hlwb tso cov tshuaj insulin ntau dua. Qhov no txhais tau hais tias nws tsuas ua qhov no thaum cov ntshav qab zib siab siab. Cov kev cai ntse no txwv tsis pub hypoglycemia thiab ua kom yooj yim los tswj cov ntshav qab zib. Kev tshawb nrhiav pom tau tias cov neeg mob muaj cov piam thaj tsawg dua tom qab noj mov thiab feem ntau cov piam thaj ruaj khov dua. Cov receptor kuj tseem ua rau lub plab khoob, uas ua rau koj xav tias puv ntev thiab txo koj cov calorie kom tsawg txhua hnub.

GIPR: Lub Zog Metabolism Reprogramming thiab Adipose Tissue Transformation

Lub hom phiaj tseem ceeb thib ob hauv Bioglutide NA-931 cov txheej txheem yog lub plab inhibitory peptide receptor (GIPR). Qhov receptor no tseem ceeb heev rau kev hloov pauv lub zog sib npaug. Thaum GIPR tau qhib rau hauv cov ntaub so ntswg adipose dawb, nws ua rau kom tso tawm adiponectin, ib yam tshuaj uas pab hlawv rog thiab ua rau insulin ua haujlwm zoo dua. Cov receptor txhawb kev hloov pauv ntawm cov rog dawb rau hauv cov metabolism hauv cov nqaij ntshiv xim av adipose los ntawm kev tig rau kev txhim kho cov protein-1 uncoupling. Qhov no txhawb nqa thermogenic metabolism thiab siv zog.

Thaum GIPR qhib, nws ua haujlwm ua ke nrog GLP-1R cov teebmeem hauv pancreatic islet hlwb. Cov sensors no ua haujlwm zoo ua ke dua li ib leeg los ntawm nws tus kheej kom nce insulin tso tawm thaum muaj piam thaj. Cov kws tshawb fawb tau pom tias ua rau ob qho tib si GIPR thiab GLP-1R tib lub sijhawm tuaj yeem txo cov ntshav qab zib hloov tom qab noj mov txog li 37% piv rau qhov pib. Cov receptor ntxiv txuag pancreatic beta hlwb los ntawm apoptosis thaum txhawb lawv txoj kev loj hlob. Qhov no tuaj yeem pab cov neeg uas muaj tus kab mob metabolic ua rau lawv lub peev xwm ua kom insulin dhau sijhawm.

GCGR: Zog Mobilization thiab Hepatic Metabolic Hloov

Bioglutide NA-931 tus qauv tsim suav nrog glucagon receptor (GCGR), uas yog qhov loj heev. Yav dhau los, qib siab ntawm glucagon tau txuas nrog cov ntshav qab zib siab. Txawm li cas los xij, kev tswj hwm kev ua haujlwm ntawm GCGR muaj cov txiaj ntsig zoo hauv metabolic thaum sib npaug nrog cov khoom sib txuas ntawm lwm cov receptor ua haujlwm. Tus receptor pib hloov metabolic hauv lub siab los ntawm kev tig rau ntawm cAMP-PKA-CREB txoj hauv kev. Qhov no nce kev ua haujlwm ntawm cov enzymes tseem ceeb gluconeogenic thiab txhawb kom lub siab siv fatty acids rau lub zog.

Qhov kev hloov pauv hauv cov metabolism no ua rau lub cev siv lub zog ntau dua thiab ua kom lub cev ketone ntau dua, uas tuaj yeem pab lub hlwb ua haujlwm zoo dua thiab txo qis kev tshaib kev nqhis. Thaum GCGR qhib, nws txhawb nqa lub paj hlwb sympathetic. Qhov no ua rau lub cev lub hauv paus metabolic npaum li cas los ntawm 12 mus rau 15 feem pua, uas yuav pab tau ntev - poob phaus. Cov receptor kuj tseem pab cov leeg nqaij noj cov piam thaj, uas ua rau insulin ua haujlwm zoo dua txawm tias muaj cov teebmeem gluconeogenic. Qhov tseem ceeb yog qhov sib npaug.Tom ntej: Bioglutide NA-931nres cov ntshav qab zib uas yuav tshwm sim yog tias tsuas yog GCGR receptors tau qhib los ntawm kev ua kom lawv nyob rau tib lub sijhawm.

IGF-1R: Muscle Preservation thiab Anabolic Balance

Bioglutide NA-931 txawv ntawm lwm cov kev kho mob metabolic vim nws tiv thaiv cov txheej txheem anabolic tseem ceeb los ntawm insulin-zoo li kev loj hlob zoo-1 receptor (IGF-1R). Qhov kev txhawb nqa ntawm receptors no kho qhov teeb meem loj nrog cov tshuaj poob phaus: lawv ua rau cov leeg poob. Los ntawm txoj kev PI3K-Akt-mTOR, IGF-1R ua kom cov protein ntau sai thaum nres lub ubiquitin-proteasome system los ntawm kev rhuav tshem cov protein.

Cov ntaub ntawv kho mob qhia tau tias cov neeg uas tau kho nrog Bioglutide NA-931 khaws lawv lub cev hnyav thaum poob phaus. Lawv tsuas poob 1.2% ntawm lawv cov leeg nqaij, piv rau 3.8% ntawm lawv cov leeg nqaij thaum lawv raug kho nrog GLP-1 receptor agonists li niaj zaus. Cov receptor pab cov leeg nqaij satellite ua haujlwm, uas pab cov nqaij fibers loj hlob thiab noj qab nyob zoo. IGF-1R kev ua haujlwm kuj tseem txhim kho mitochondrial ntau lawm hauv cov leeg nqaij, uas ua rau cov leeg nqaij cov metabolism hloov tau yooj yim thiab nws muaj peev xwm siv cov rog kom lub zog zoo dua. Qhov txiaj ntsig no tshwj xeeb tshaj yog pab rau cov neeg laus thiab cov neeg uas muaj kev pheej hmoo ntawm sarcopenia.

Puas Bioglutide NA-931 Quadruple Receptor Agonism Coordinate Metabolic Signaling li cas?

Cov ntaub so ntswg-Tshwj xeeb Receptor Distribution tsim cov txiaj ntsig rau lub hom phiaj

Bioglutide NA-931 tus txheej txheem ntse tswj xyuas thiab cov txheej txheem metabolic ntawm cov ntaub so ntswg tshwj xeeb receptor qhia. Lub siab hlawv rog thiab siv zog vim nws muaj GCGR ntau. Cov tshuaj activates hepatic GCGR, uas hlawv rog kom txo steatosis thiab nce ketone tiam yam tsis tau nce ntshav qab zib.

Txawm li cas los xij, pancreatic beta hlwb muaj GLP siab -1R thiab GIPR tab sis GCGR qis. Hom receptor no qhia txog Bioglutide NA-931 feem ntau txhim kho pancreatic cov ntaub so ntswg insulin tso tawm thiab beta cell tiv thaiv, tsis yog gluconeogenic signaling. Vim tias qhov cuam tshuam yog cov ntaub so ntswg tshwj xeeb, tsis muaj kev txhawj xeeb ntxiv lawm tias kev tso tawm insulin thiab glucagon ua haujlwm tib lub sijhawm yuav cuam tshuam cov metabolism. Hloov chaw, txhua cov ntaub so ntswg teb raws li nws cov qauv qhia receptor, ua rau cov tshuaj biochemical ua haujlwm zoo.

Ua kom GCGR thiab GLP-1R pab lub cev txo cov rog, thaum cov nqaij mos muaj ntau IGF-1R, uas xa cov cim muaj zog anabolic kom khaws cov nqaij ntshiv. Thaum GIPR thiab GLP-1R koom nrog, cov ntaub so ntswg adipose khaws cov roj tsawg thiab ua kom sov ntau dua. Bioglutide NA-931 txhim kho cov metabolism hauv ntau txoj hauv kev yam tsis muaj qhov tsis zoo ntawm kev kho tib lub hom phiaj txij li nws lub hom phiaj ntawm lub cev.

Teeb liab Txoj Kev Hla -Hais lus Amplifies Therapeutic Benefits

Plaub receptors Bioglutide NA-931 activates muaj teeb meem tshuaj sib cuam tshuam uas txhawb kev kho. GLP-1R activates cAMP signaling saw uas txhawb nqa GIPR adiponectin tso tawm. Qhov kev tawm tswv yim zoo no txhim kho cov tshuaj insulin ntau dua li txhua tus neeg txais ib leeg. Vim kev sib tham sib tham, dual GLP-1R / GIPR agonists muaj cov teebmeem metabolic ntau dua li cov ntshiab.

GCGR qhib txoj hauv kev AMPK, uas nce IGF-1R- pib mTORC1 signaling. Qhov kev sib txuas no tiv thaiv cov leeg nqaij protein degradation los ntawm GCGR ua kom, uas siv zog ntau dua. Cov txheej txheem no cuam tshuam cov tshuaj lom neeg los tsim lub xeev metabolic uas pab lub cev txo cov rog, khaws cov leeg nqaij, thiab ua insulin-sensitive. Kev muab tshuaj ib hom phiaj ib ntus yog qhov nyuaj.

Kev hloov pauv ntawm cov kev sib koom tes no ua rau lawv muaj txiaj ntsig zoo dua. GLP-1R txo qis qab los noj mov hauv 30 feeb tom qab tswj hwm. Rau ob mus rau plaub teev tom qab noj mov, GIPR cuam tshuam cov metabolism, ua rau kev siv cov khoom noj yooj yim dua. GCGR thiab IGF-1R ua kom txhawb nqa cov txiaj ntsig metabolic thoob plaws 24-teev lub sijhawm noj, txhawb kev siv zog thiab kev loj hlob ntawm cov leeg txawm tias tshaib plab.

Cov Lus Qhia Txog Kev Tswj Xyuas Kev Nyab Xeeb Metabolic

Bioglutide NA-931's quadruple receptor mechanism muaj cov lus qhia tawm tswv yim los tiv thaiv kev ua haujlwm dhau ntawm txhua txoj hauv kev. Thaum GCGR stimulation ua rau kom cov piam thaj hauv siab synthesis, GLP-1R thiab GIPR cov dej num nce pancreatic insulin ntau lawm, tiv thaiv hyperglycemia. IGF-1R thiab adiponectin boost insulin efficiency thiab txo cov piam thaj nce.

GLP-1R kev ua ub no tuaj yeem tsim cov caloric tsis txaus thiab cov leeg nqaij tawg, txawm hais tias IGF-1R stimulation ua kom cov protein synthesis txuas ntxiv mus. Qhov kev ntsuas tus kheej no sib txawv ntawm ntau lub hom phiaj agonists los ntawm kev sib xyaw tshuaj. Kev sib koom pharmacokinetics thiab kev sib koom ua ke ntawm cov neeg txais tau txais kev sib koom ua ke ntawm cov molecule cov teebmeem.

Kev nyab xeeb yog nce los ntawm qhov kev thov rau cov piam thaj rau GLP-1R thiab GIPR insulin tso tawm. Sulfonylureas txhim kho insulin tso tawm tsis hais cov piam thaj hauv ntshav, tab sis cov receptors tsuas yog ua li ntawd thaum cov piam thaj siab. Qhov no piav qhia yog vim li cas Bioglutide NA-931 kev sim tshuaj muaj qhov tsawg kawg nkaus ntawm hypoglycemia txawm tias txhim kho glycemic tswj.

Bioglutide NA-931 Mechanism of Integrated Endocrine thiab Metabolic Pathway Activation

Hypothalamic{0}}Pituitary Integration Tsim Systemic Metabolic Teb

Tshaj li txo kev tshaib kev nqhis,Tom ntej: Bioglutide NA-931cuam ​​tshuam rau hauv nruab nrab paj hlwb. Brain GLP-1 receptors koom ua ke cov ntaub ntawv hais txog kev noj zaub mov, lub zog, thiab cov metabolism. Thaum ua haujlwm, cov sensors sib txuas lus nrog lub hlwb thaj tsam uas tswj hwm khoom plig, impulses, thiab kev xaiv noj zaub mov. Lub paj hlwb nqi zog ua haujlwm tsawg dua thaum cov tib neeg saib ntawm cov zaub mov muaj calorie ntau, raws li neuroimaging. Lawv txoj kev xav noj mov tau hloov pauv, tsis yog lawv txoj kev qab los xwb.

Lub hypothalamus tswj hwm ntau cov tshuaj hormonal raws li hypothalamic -pituitary axis. Kev loj hlob ntawm cov tshuaj hormones ib txwm txhawb nqa IGF-1R cov txiaj ntsig txhawb kev loj hlob. Cov thyroid ua haujlwm zoo boosts basal metabolism. Cov tshuaj hloov lub hlwb kev nyuaj siab teb circuits, uas yuav piav qhia vim li cas qee cov neeg mob noj tsawg dua thaum chim siab thiab daws kev ntxhov siab zoo dua thaum kho.

Cov kev sib txuas ntawm neuroendocrine no nce cov metabolism dhau ntawm cov receptors. Cov neeg mob feem ntau pw tsaug zog zoo dua, txhim kho txoj hnyuv. Central anti-cov txheej txheem inflammatory thiab nce qib adiponectin txo qhov mob. Bioglutide NA-931 hloov tag nrho cov tshuaj hormones, tsis zoo li cov tshuaj metabolic.

Adipose ntaub so ntswg Remodeling los ntawm kev sib koom tes Receptor Activation

Bioglutide NA-931 tswj cov metabolism hauv cov ntaub so ntswg adipose. GIPR darkens dawb rog. Nce mitochondrial ntom thiab uncoupling protein-1 qhia. Qhov no hloov lub zog khaws cov rog dawb rau hauv cov roj thermogenic xim av. Active GLP-1R txo qis adipocyte edema thiab txhawb kev sib txawv.

GCGR npaj khaws cia triglycerides rau combustion. Synchronized daim siab thiab cov leeg ua haujlwm oxidises dawb fatty acids kom tsis txhob muaj kev puas tsuaj rau cov hlab ntsha. IGF-1R activation nyob rau hauv adipose cov ntaub so ntswg stromal hlwb remodels ntaub so ntswg, txwv ceev ceev poob-induced fibrosis thiab o.

Qhov tshwm sim yog rog tsis muaj teeb meem metabolic. Txo cov roj visceral thiab tsis hloov pauv cov roj subcutaneous yog qhov kev tshawb pom. Cov qauv no txhim kho cov metabolism. Cov ntaub so ntswg adipose zoo dua insulin rhiab heev txo lub cev - dav cytokines. Cov ntaub so ntswg hloov pauv nce ntshav siab, roj cholesterol, metabolic syndrome, thiab lub siab ua haujlwm.

Hepatic Metabolic Flexibility thiab Fat Oxidation Enhancement

Bioglutide NA-931 hloov pauv cov metabolism hauv siab heev. Fatty acid-degrading enzymes hlawv lub siab rog thaum GCGR qhib. Triglycerides, uas ua rau tsis muaj dej cawv fatty siab kab mob, raug txo. Ketone ntau lawm boosts hlwb roj thiab yuav txo tau kev tshaib kev nqhis.

Lub siab ua insulin-sensitive vim GLP-1R thiab GIPR. Qhov no txo ​​qis ntshav qab zib yoo mov hyperglycemia- ua rau gluconeogenesis. Kev sib npaug ntawm GCGR gluconeogenic activation thiab insulin rhiab heev ua rau lub siab ua kom cov piam thaj hauv siab kom tsis txhob muaj ntshav qab zib tsawg tab sis tsis yog hyperglycemia. Kev tswj tsis yooj yim yog nyuaj nrog cov tshuaj ib leeg.

Ua kom IGF-1R nyob rau hauv cov kab mob siab hepatic stellate tuaj yeem pab cov neeg mob mob siab rau mob fibrosis. Txoj kev tshawb fawb ua ntej qhia tau hais tias ntev- kev kho mob yuav txo qis kev tsim collagen thiab txhim kho daim siab ua haujlwm. Bioglutide NA-931 kho cov kab mob metabolic-associated fatty siab kab mob thiab khaws lub siab. Nws hais txog cov kab mob metabolic ua rau thiab cuam tshuam.

Vim li cas Quadruple Receptor Activity tseem ceeb hauv Bioglutide NA-931 Function?

Kev kov yeej ib leeg -Cov Kev Cai Kho Mob Lub Hom Phiaj

Ib txwm siv ib zaug -cov kev kho mob metabolic feem ntau ua tsis tiav vim yog cov nyiaj hormonal. Selective GLP-1R agonists pib pab cov neeg mob poob phaus ntau, tab sis lawv qeeb metabolism thiab nce kev tshaib kev nqhis, tsim kom muaj qhov hnyav hnyav. Poob cov nqaij ntshiv thaum noj zaub mov qeeb metabolism, ua rau qhov hnyav poob nyuaj.

Bioglutide NA-931's plaub-Ib feem txheej txheem tswj kev them nyiaj rov qab ib txhij. GLP-1R txo qis qab los noj mov, thaum GCGR txhawb cov metabolism los pab txhawb kev txwv calorie. Ua kom IGF-1R tiv thaiv cov leeg, lub cev cov ntaub so ntswg tshaj plaws. Multi-receptor therapy prolongs yuag poob los ntawm kev tiv thaiv lub cev tsis kam.

Txoj kev no kuj tseem txo qis receptor pathway ntau npaum li cas. Qhov siab tshaj plaws receptor activation tuaj yeem ua rau muaj kev phiv ntau dua, qhov nruab nrab receptor ua kom muaj kev nyab xeeb dua thiab siv tau zoo dua. Txawm hais tias muaj kev cuam tshuam tsis zoo ntawm plab zom mov tsawg dua li siab - koob tshuaj xaiv GLP-1R agonists, bioglutide NA-931 txo qhov hnyav dua. Qhov no qhia txog ntau lub hom phiaj 'cov txiaj ntsig tiag tiag.

Hais txog Metabolic Disease Complexity Holistically

Ob qho tib si rog thiab ntshav qab zib hom 2 yog txuas. Cov teeb meem metabolism suav nrog kev tshaib kev nqhis, insulin tsis kam, cov nqaij rog rog, mob siab steatosis, leeg nqaij insulin insensitivity, thiab beta cell tsis ua haujlwm. Kev kho ib qho teeb meem yam tsis tau hais txog lwm tus yuav tsis ua haujlwm. GLP-1R agonists tuaj yeem txo cov ntshav qab zib, txawm hais tias plab rog thiab rog rog tuaj yeem tshwm sim.

Bioglutide NA-931 quadruple receptors tswj qhov tsis sib xws. GIPR thiab GLP-1R tswj cov piam thaj thiab qab los noj mov. Cov rog rog thiab lub zog tso tawm raug cuam tshuam los ntawm GCGR. IGF-1R tswj cov tshuaj hormones thiab cov leeg nqaij metabolism. Txhua lub hom phiaj receptor kho cov txheej txheem kab mob sib txawv, yog li cov tshuaj ua haujlwm rau txhua yam kab mob metabolic.

Cov txiaj ntsig ntawm cov tswv yim holistic no mus dhau lub hom phiaj metabolic. Cov neeg mob cov roj cholesterol, cov cim inflammatory, thiab ntshav siab zoo. Lub neej zoo txhim kho nrog txo qhov hnyav, kev tawm dag zog, thiab tsawg dua cov kab mob. Txij li thaum nws boosts metabolism, bioglutide NA-931 yuav kho cov kab mob.

Ua kom muaj kev tswj hwm qhov ncauj los ntawm kev tsim qauv me me

Bioglutide NA-931's me me molecular shapes renders nws nkag tau thaum noj qhov ncauj, ib tug feature nquag overlooked. Cov neeg mob tawm tsam ua raws li lawv cov kev kho mob txij li cov tshuaj GLP-1 receptor agonists yog cov tshuaj peptide txhaj rau hauv qab ntawm daim tawv nqaij. Ntau tus neeg mob zam cov koob lossis pom cov sijhawm txhaj tshuaj tsis zoo, yog li lawv txiav tawm txoj kev kho, thiab qhov mob hnyav dua.

Qhov ncauj nojTom ntej: Bioglutide NA-931ua kom yooj yim dua kom tau txais thiab khaws cia. Cov tshuaj yuav noj zoo li lwm cov ntsiav tshuaj, tshem tawm qhov xav tau ntawm cov koob thiab lawv thab plaub. Qhov zoo li yooj yim ntug no cuam tshuam rau -kev ua tau zoo hauv ntiaj teb. Kev sim tshuaj ntsuam xyuas pom tau tias kev ua raws li 85%, ntau dua li kev txhaj tshuaj. Kev ua raws cai zoo dua tau txais txiaj ntsig ntev dua - kav ntev, cov txiaj ntsig kho tau zoo dua.

Cov qauv me me molecule pab tsim thiab ruaj khov. Cov khoom tsis xav tau tub yees, ua kom yooj yim khaws cia thiab faib khoom yooj yim. Kev tsim khoom nce qib zoo dua li kev siv tshuaj lom neeg peptide. Vim yog cov laj thawj no, Bioglutide NA-931 tuaj yeem siv los ntawm cov neeg mob ntau dua, tshwj xeeb tshaj yog nyob rau hauv cov chaw uas muaj kev kho mob tsis muaj zog.

Kauj Ruam -los ntawm -Piv txwv ntawm Bioglutide NA-931 Multi-Receptor Metabolic Mechanism

Initial Absorption thiab Receptor Binding Kinetics

Tom qab kev tswj hwm qhov ncauj, Bioglutide NA-931 tau nkag los ntawm lub plab zom mov. Daim ntawv me me tso cai yooj yim dhau los ntawm lub plab epithelial hlwb. Txoj kev siv tshuaj ntau lawm nce bioavailability, thiab cov qib ntshav plasma siab tshwm sim hauv ib mus rau ob teev. Cov ntshav ntau npaum li cas los ntawm ib lub cev thiab muaj pes tsawg tus receptors nws tau txiav txim siab qhov twg cov tshuaj mus.

Cov tshuaj tuaj yeem txuas rau plaub hom receptor ib txhij vim nws cov khoom tshwj xeeb. Txawm hais tias txhua tus receptor qhov tshwj xeeb khi qhov chaw qauv, Bioglutide NA-931 cov tshuaj lom neeg txuas nrog universal receptor seem. Cov kev sib txuas affinity muaj zog txaus los kho, tab sis tsis muaj zog heev uas nws occupies lub receptor ntev dhau lawm, ua rau lub cev tsis teb.

Cov kev hloov hauv cov duab pib intracellular signaling txoj kev thaum receptors khi. varied receptors muaj qee tus nqi sib txawv, yog li cuam tshuam tshwm sim nyob rau hauv ib theem zuj zus. Kev ua kom nrawm GLP-1R txo qis qab los noj mov hauv ib teev. Kev hloov pauv hauv enzyme qhia ntau ntau teev ua ke GIPR thiab GCGR cov teebmeem. Nws yuav siv sij hawm 6-12 teev rau IGF-1R los hloov cov protein synthesis. Qhov no staggered stimulation npog cov metabolism hauv thoob plaws qhov ntau npaum.

Intracellular Signaling Cascade Activation thiab Hla- Tham

Bioglutide NA-931 qhib ntau lub xov tooj ntawm tes taw qhia txoj hauv kev thaum nws khi rau nws lub hom phiaj receptors. GLP-1R thiab GIPR qhib adenylyl cyclase thiab nce cyclic AMP ntawm kev khi rau Gs proteins. Tus tub txib thib ob no ua rau cov protein kinase A, uas phosphorylates downstream lub hom phiaj, xws li cov khoom siv hloov pauv uas tswj cov kev qhia gene. Txoj kev cAMP-PKA nce insulin, txo glucagon, thiab tsim adiponectin.

Txawm hais tias GCGR ua kom nce cAMP hauv ntau lub xov tooj ntawm tes, qhov tshwm sim muaj ntau yam. Lub teeb liab cAMP ua rau CREB transcription factor hauv hepatocytes, uas ua rau cov piam thaj thiab rog- hlawv cov noob. Tib tus tub txib thib ob rhuav tshem cov roj adipocytes. Vim hais tias txhua hom cell muaj ntau yam PKA substrates thiab cov kev tswj cov noob, cov ntaub so ntswg sib txawv tau cuam tshuam.

Los ntawm receptor tyrosine kinase kev ua haujlwm, IGF-1R qhib txoj hauv kev. Autophosphorylation tshwm sim thaum ligands khi receptors. Adapter proteins uas tso tawm PI3K-Akt thiab Ras-MAPK txoj hauv kev txuas ntawm no. Cov txheej txheem no tsim cov proteins, txhawb nqa cov hlwb, thiab hloov cov metabolism. Bioglutide NA-931's metabolic profile yog qhov tshwj xeeb vim tias GLP-1R / GIPR / GCGR cAMP txoj hauv kev thiab IGF-1R kev loj hlob ntawm kev sib koom ua ke.

Sustained Metabolic Remodeling thiab Adaptation

Ntev -lub sij hawm bioglutide NA-931 kev kho mob ua rau lub sijhawm ntev ntawm cov cellular thiab cov ntaub so ntswg hloov pauv biochemical. Lub siab thiab cov leeg hloov cov noob qhia los txhawb cov metabolism hauv aerobic. Cell zog tsim thiab mitochondrial biogenesis nrawm. Ntau cov ntshav khiav thiab txo qis qhov mob tshwm sim los ntawm cov ntaub so ntswg adipose restructuring.

Ntev -lub sij hawm GLP-1R/GIPR stimulation ua rau kom cov insulin ntau lawm thiab cov piam thaj hauv cov pancreatic beta hlwb. Kev tuag tsawg dua thiab kev loj hlob qeeb tuaj yeem ua rau muaj beta cell loj. Cov kev hloov kho no pab txiav txiav tswj cov piam thaj, uas tuaj yeem cuam tshuam li cas hom 2 mob ntshav qab zib tua beta hlwb.

Neuroplastic hloov nyob rau hauv lub hlwb yuav hloov kev nyiam noj thiab tus cwj pwm. Txoj kev muab nqi zog txoj kev nkag siab rau cov zaub mov txaus nyiam txo qis thaum lub teeb liab puv nce. Cov kev hloov pauv ntawm lub hlwb no khaws kev kho mob -kev hloov pauv kev noj haus. Kev hloov pauv hauv cov metabolism thiab kev coj tus cwj pwm tsim kom muaj qhov sib npaug tshiab nrog kev noj qab haus huv, txo qhov hnyav, thiab siab dua insulin.

Xaus

Lub discovery ntawmTom ntej: Bioglutide NA-931txhawb kev kho mob metabolic. Cov khoom me me no ib txhij ua rau GLP-1R, GIPR, GCGR, thiab IGF-1R. Qhov no pib ua cov lus teb metabolic uas hais txog ntau yam rog rog thiab cov teeb meem ntshav qab zib hom 2. Lub quadruple receptor mus kom ze zam ib leeg-lub hom phiaj kev kho teeb meem los ntawm kev tiv thaiv cov lus teb, tswj cov metabolic thaum lub sij hawm txo qhov hnyav, thiab tswj lub cev hnyav.

Cov kev tshawb fawb soj ntsuam tau qhia tias bioglutide NA-931 txhim kho lub cev qhov hnyav, tswj glycemic, thiab cov ntsuas metabolic syndrome thaum ua tau zoo. Kev kho qhov ncauj yog qhov yooj yim dua kom tau txais thiab feem ntau yuav ua raws li kev txhaj tshuaj. Cov tshuaj no tuaj yeem hloov pauv kev kho mob metabolic thaum Theem III kev tshawb nrhiav kev nce qib thiab kev lag luam pib.

To taub tias Bioglutide NA-931 ua haujlwm li cas yuav pab peb txhim kho cov kev kho mob metabolic uas siv lub cev tsis yooj yim dua li ua kom yooj yim cov txheej txheem mob. Qhov no multi-receptacle mus kom ze yuav tsum replicated rau lwm yam complex ntev- cov kab mob uas ib leeg-lub hom phiaj cov tshuaj tsis ua hauj lwm.

FAQ

Koom tes nrog BLOOM TECH rau Pharmaceutical -Qib Bioglutide NA-931 Supply

Raws li kev tsim nyogTom ntej: Bioglutide NA-931tus neeg muag khoom, Shaanxi BLOOM TECH Co., Ltd. muaj cov kws tshuaj - qib cov ntaub ntawv tsim nyob rau hauv GMP- cov chaw muaj ntawv pov thawj pom zoo los ntawm US-FDA, EU, thiab CFDA cov cai tswj hwm. Peb 12 xyoo ntawm kev paub nyob rau hauv cov organic synthesis thiab kws tshuaj intermediates kom zoo ib yam, sis tw nqi, thiab txhim khu kev qha khoom chains rau kev tshawb fawb cov koom haum thiab kws manufacturers thoob ntiaj teb. Peb muab cov ntaub ntawv pov thawj zoo, suav nrog COA, cov lus qhia tshwj xeeb, thiab cov ntaub ntawv tswj hwm kev tswj hwm, txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm rau txhawm

Peb cov qauv kev them nqi pob tshab tswj cov nyiaj tau los ruaj khov thaum hla tus nqi ncaj qha rau cov neeg siv khoom, ua kom muaj kev sib koom tes ntev ntev -. Txawm hais tias koj xav tau kev tshawb fawb kom muaj nuj nqis lossis kev lag luam - teev ntau lawm, peb pab pawg kws tshaj lij muab cov kws tshaj lij kev sib tham txog kev ua kom zoo dua qub thiab cov kev xav tau zoo. Hu rau peb pab neeg muag khoom ntawmSales@bloomtechz.comlos tham txog koj cov kev xav tau Bioglutide NA-931 thiab tshawb pom tias BLOOM TECH cov kev pabcuam sib koom ua ke tuaj yeem ua kom koj cov kab mob metabolic tshawb fawb thiab kev loj hlob.

Cov ntaub ntawv

1. Müller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill H. RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschöp MH. Glucagon-zoo li peptide 1 (GLP-1). Molecular Metabolism . 2019; 30: 72-130.

2. Killion EA, Lu SC, Fort M, Yamada Y, Véniant MM, Lloyd DJ. Glucose-dependent insulinotropic polypeptide receptor kev kho mob rau cov kab mob metabolic. Peptides. 2020; 125:170203.

3. Samms RJ, Coghlan MP, Sloop KW. GIP tuaj yeem txhim kho kev kho mob ntawm GLP-1 li cas? Trends in Endocrinology and Metabolism. 2020;31(6):410-421.

4. Hartman ML, Sanyal AJ, Loomba R, Wilson JM, Nikooienejad A, Bray R, Karanikas CA, Duffin KL, Robins DA, Haupt A. Cov teebmeem ntawm cov tshiab dual GIP thiab GLP-1 receptor agonist tirzepatide ntawm biomarkers ntawm nonalcoholic type2 mob ntshav qab zib steato. Kev Kho Mob Ntshav Qab Zib. 2020;43(6):1352-1355.

5. Holst JJ, Rosenkilde MM. GIP raws li lub hom phiaj kho mob ntshav qab zib thiab rog rog: kev pom los ntawm incretin co-agonists. Phau ntawv Journal of Clinical Endocrinology and Metabolism. 2020;105(8):e2710-e2716.

6. Nauck MA, Meier JJ, Cavender MA, Abd El Aziz M, Drucker DJ. Cov kev ua ntawm cov hlab plawv thiab cov txiaj ntsig kev kho mob nrog glucagon-zoo li peptide-1 receptor agonists thiab dipeptidyl pedtidase-4 inhibitors. Kev xa tawm . 2017; 136(9): 849-870.